Pharmacist Medical Marijuana CPE
$179.00
Target Audience
This activity has been designed to meet the educational needs of pharmacists involved in the care of patients who are considering using medical marijuana as part of their care plan in States that recognize marijuana as a medical treatment.
Program Agenda
- Module 1: History and Legal Landscape
- Module 2: The Discovery of the Endocannabinoid System
- Module 3: The Endocannabinoid System
- Module 4: Cannabinoids and Terpenes
- Module 5: Studies on Therapeutic Uses
- Module 6: Cannabis and Opioids in Chronic Pain Treatment
- Module 7: Side Effects and Chronic Effects
Course is available online from September 13, 2020 through September 13, 2022
Estimated time to complete activity: 10 hours
If you are a medical group or network and need multi-seat pricing, please call 844.411.0500 x813
Program Overview
The activity is an educational overview of medical cannabis in its current legal context in the US. Currently there are 2.1 million registered medical marijuana patients and there are an estimated 3.5 million patients using medical marijuana nationwide. The constantly changing legal environment in which cannabis can be used in the United States has resulted in confusion for both physicians and patients. Currently, 33 states have legalized medical marijuana and 10 states have also legalized recreational marijuana. Due to the lack of knowledge of the legality of discussing medical marijuana, physicians, nurses and pharmacists are hesitant to discuss with their patients. The lack of communication between the patient and physician can lead to the patient self-medicating with no guidance from a medical professional.
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 10 contact hours (1.0 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.
UAN # 0761-9999-20-239-H01-P; 0761-9999-20-239-H01-T
Credit Designation
SynAptiv designates this enduring material for a maximum of 10 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Program expires 9/13/2022
Estimated time to complete activity: 10 hours
Disclosure Statement
Your CE Source ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, SynAptiv identifies conflicts of interest with its instructors, planners, content managers, and other individuals who are in a position to control the content of an activity.
The following faculty, planner and/or content manager reported the following financial relationship with commercial interests whose products or services may be mentioned in this CE activity:Royalty/Patent Holder for Medical Cannabis Textbooks Consulting Fees: Callitas Therapeutics
After completing this activity, the participant should be better able to:
- Interpret the legal context in which cannabis can be discussed with a patient and how states can have legalized medical marijuana even though it is recognized as a federally illegal substance.
- Compare and relate the historical medicinal uses of marijuana to modern resurgence in patient use of medical marijuana.
- Explain why there is a lack of clinical studies due to Schedule I classification of marijuana.
- Summarize and explain the discovery of the Endocannabinoid System and how its discovery has led to further research into how cannabinoids interact with the receptors.
- Summarize the function of the Endocannabinoid System in the regulation of the body through a vast network of receptors involved in maintaining homeostasis, neuroprotection, and other regulatory functions.
- Discuss and interpret how cannabinoids and terpenes affect the Endocannabinoid receptor system.
- Assess pros and cons of cannabinoids and their effects on the symptoms of ailments such as anxiety, chronic pain, epilepsy, gastrointestinal disorders, neurodegenerative illnesses, post-traumatic stress and migraines.
- Evaluate the current research studies regarding opioids versus cannabinoids in the treatment of the symptoms of chronic pain.
- Discuss side effects and contraindications of medicinal cannabis and safety concerns with its use.
- Identify signs of abuse, misuse and chronic effects of marijuana use.
- 10 AMA PRA Category 1 Credits™
- Instant access to all course materials
- Printable and downloadable infographics
- All research materials used for the online course
- Lifetime, unlimited access
- 24/7 access
- No time limits
- Start anytime
- Work on your own time and at your own pace
- Affordably priced
Dr. Gregory Smith has been in primary care practice for over 30 years. He is board certified in Preventive Medicine and obtained his MPH from Harvard University. He first trained on the use of medical cannabis in 2000 in California. He has written extensively on the subject, including his popular textbook, “Medical Cannabis: Basic Science and Clinical Applications” published in 2016, and more recently “Cannabidiol, CBD: What you need to know.” And most recently in 2019, “THCV: Appetite Killer.”
Dr. Kevin Smith has also been in primary care practice for over 30 years. He is board certified in Preventive Medicine and obtained his MPH from Yale University. He trained on the use of medical Cannabis several years ago and has been very active in educating physicians and other medical professionals.
Disclosure Statement
SynAptiv ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, SynAptiv identifies conflicts of interest with its instructors, planners, content managers, and other individuals who are in a position to control the content of an activity.
The following faculty, planner and/or content manager reported the following financial relationship with commercial interests whose products or services may be mentioned in this CE activity:Royalty/Patent Holder for Medical Cannabis Textbooks Consulting Fees: Callitas Therapeutics
Comments
21 reviews for Pharmacist Medical Marijuana CPE
Add a review
You must be logged in to post a comment.
More discussion on different strains and their usage
Overall outstanding.
Include video content to give an additional visual+audio resources to describe the effects of endocannabinoids and cannabinoids on the ECS
I really appreciate this information being put together in such a comprehensive manner. Very well written and easy to follow and “digest”. I would love more information (in depth) with regard to drug interactions to be more aware of or information to offer patients when they inquire about certain meds they take and what to expect with their medical cannabis use. I believe Chris N. has given me some other references to consider. Many thanks, Betsy
I enjoyed these activities. They gave me a good foundation to proceed to the medical healthcare consultant certification for pharmacists.
I was completely satisfied
Great program, especially the graphics used. The more graphs, charts, and tables and less prose used, the better it can become.
Great charts that gave a visual guide to the points bieng taught
the content was enjoyable
Obviously needs more research, but when we look at overall landscape of current treatments for many chronic issues, always good to have an alternative.
I enjoyed the learning activity.
I was a good overall review of cannabis use.
add some lecture components
Overall excellent. I would suggest that the graphics be enlarged so that they are more readable.
At end more information on different straina
No change needed.
I felt the information was constantly defending cannabis. Generally it is true the lack of studies make it difficult to provide good information on use of it and I found the information to be helpful in realizing all the systems cannabis affects, but to me that means it can have a lot of unexpected effects,NOT that is is effective in treating all these systemic issues.
nothing to improve
Excellent program thank you – I am already pretty knowledgeable in the area as I am a dispensary pharmacist, but expanded my knowledge of ECS and mechanisms by which cannabis works
I felt that this CPE was far superior to any other on the topic of Medical Marijuana.
Very thorough
Fantastic, more discussion on subtle therapeutic differences between different strains (indica v. sativa) and strains with different cannabinoid concentrations (THC, CBD) would also be valuable.